Skip to main content
. 2014 Oct;26(5):248–258. doi: 10.11919/j.issn.1002-0829.214080

Table 1.

Characteristics of included reviews

study trials/
participants
age
range
SSRIs compared
to placebo
diagnoses
considered
outcome
measures
Beasley
1991[7]
17/
2334
12-90 fluoxetine depression suicidal acts
suicidal ideation
Khan
2000[26]
14/
6356
general
population
paroxetine; sertraline not specified suicide
 suicide attempt
Fergusson
2005[8]
189/
18,413
general
population
not specified depression suicide
suicide attempt
Gunnell
2005[11]
477/
40,826
adults fluoxetine; paroxetine;
sertraline; fluvoxamine;
citalopram; escitalopram
not specified suicide
 self-harm
suicidal thoughts
Dubicka
2006[24]
unknown/
2122
6-18 fluoxetine; paroxetine;
sertraline; citalopram
MDD suicide attempt
self-harm
preparatory acts
suicidal thought
Hammad
2006[25]
16/
2970
pediatric
patients
fluoxetine; paroxetine;
sertraline; fluvoxamine;
citalopram
MDD,OCD,SAD suicidality
Apter
2006[20]
5/
1191
<18 paroxetine MDD,OCD,AD suicidality
Bridge
2007[18]
27/
3543
<19 fluoxetine; paroxetine;
sertraline; fluvoxamine;
and escitalopram or
citaloprama
MDD,OCD,AD suicide attempt
preparatory act
suicidal ideation
Tauscher-
Wisniewski
2007[19]
53/
11,448
18-65 fluoxetine Bulimia,OCD suicidal behaviors
suicidal ideation
Beasley
2007[21]
18/
3751
>18 fluoxetine MDD suicidal behaviors
suicidal ideation
Stone
2009[23]
372/
52,665
15-99 fluoxetine; paroxetine;
sertraline; fluvoxamine;
citalopram; escitalopram
not specified suicidality
Carpenter
2011[22]
61/
14,911
18-64 paroxetine depression,
OCD,AD,PTSD
suicidal behaviors
suicidal ideation

SSRI,selective serotonin reuptake inhibitor                    MDD,major depressive disorder

OCD,obsessive-compulsive disorder                              AD,anxiety disorder

SAD,social anxiety disorder (subtype of anxiety disorder)      PTSD,posttraumatic stress disorder

a in this study results for escitalopram and citalopram were analyzed together,not separately